tinzaparin


Also found in: Wikipedia.

tinzaparin

 [tin-zap´ah-rin]
a low-molecular-weight heparin obtained by depolymerization of heparin from porcine intestinal mucosa using a bacterial enzyme; it acts as an anticoagulant and antithrombotic and is used as an adjunct to warfarin in the treatment of deep venous thrombosis with or without pulmonary embolism, administered subcutaneously.

tinzaparin

/tin·zap·a·rin/ (tin-zap´ah-rin) a low-molecular-weight heparin of porcine origin, having antithrombotic activity and used with warfarin in the treatment of deep venous thrombosis with or without pulmonary embolism.

tinzaparin

[tin-zap′ah-rin]
a low-molecular-weight heparin obtained by depolymerization of heparin from porcine intestinal mucosa by using a bacterial enzyme. It acts as an anticoagulant and antithrombotic and is used as an adjunct to warfarin in the treatment of deep venous thrombosis with or without pulmonary embolism and is administered subcutaneously.

tinzaparin

Innohep® Vascular disease An LMW heparin for preventing and treating DVT, PTE. See Low-molecular weight heparin.

tinzaparin

A LOW MOLECULAR WEIGHT HEPARIN drug that interferes with the action of Factor Xa in the blood coagulation cascade and can be used to prevent blood clotting within the blood vessels in people undergoing surgery. A brand name is Innohep.
References in periodicals archive ?
Dalteparin, darbepoetin, dasatinib, dexamethasone + neomycin sulphate + polymyxin B sulfate, epoetin beta, epoetin theta, epoetin zeta, erlotinib, estradiol + cyproterone, etoricoxib, everolimus, follitropin beta, formoterol + beclomethasone, fusidic + betamethasone, fusidic + hydrocortisone , goserelin, hydromorphone hydrochloride, ketorolac, levothyroxine + liothyronine, Linezolid, nadroparin, paliperidone palmitate, pazopanib, pegfilgrastim, piribedil, progesterone, prothipendyl, Reviparin, risperidone, sildenafil, sumatriptan, tinzaparin, tobramycin, tobramycin + dexamethasone, voriconazole.
Other well-studied LMWHs include dalteparin and tinzaparin.
Low-Molecular-Weight Heparin More Effective Than Warfarin in Preventing Clot Recurrence in Cancer Patients A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients C the CATCH Study[ LBA-2 ]
56) including 100 UC cases with mild or moderate activity, tlicy reported that tinzaparin was not superior to placebo.
In all subjects receiving the drug, there was a rapid reduction in anti-Xa activity, a measurement of LMWH action, and a rapid and complete reversal of the anticoagulant action of tinzaparin, a specific form of LMWH.
Data from the Tinzaparin in Acute Ischemic Stroke Trial (TIAST).
Blumgart that a resident ordered Tinzaparin Sodium, 4,500 units by injection subcutaneously daily, but it was discontinued by another on November 30, 2005, because of concern about employing anticoagulants in patients at that stage with a hepatic resection.
There are currently three LMWHs available in Canada: enoxaparin, dalteparin, and tinzaparin (see Table One).
LMWH preparations evaluated were certoparin, dalteparin, enoxaparin, nadroparin, reviparin, and tinzaparin.
The following drugs were checked: granisetron, ondansetron, tropisetron, dolasetron, alizapride, zolpidem, tianeptine, methylprednisolone, fluoxetine, dextropropoxyphene, acetaminophen, enoxaparin, nifedipine, bromazepam, lorazepam, chlorazepate, levothyroxine, zopiclone, tinzaparin, cetirizine, simvastatin, famotidine, glibenclamide, and omeprazole.
Observational data suggests that both heparin and tinzaparin appear to bind on a one-to-one molecular basis with PMX-60056.
Innohep Tinzaparin prophylaxis against thromboembolic complications in brain tumor patients Abstract ID: 1539 J Vredenburgh, MD, Robert Preston Tisch Brain Tumor Center; USA Poster #A11 Time: Sunday, June 4, 2006; 8:00 a.